US10800769B2

Heterocyclic inhibitors of ATR kinase

University of Texas System

Abstract

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Maria Emilia Di Francesco
Priority date: July 13, 2017
Filing date: July 10, 2019
Grant date: October 13, 2020
Publication date: October 13, 2020
Language: en
PDF source: https://patentimages.storage.googleapis.com/9c/16/f9/a2d375bb8118b4/US10800769.pdf
Metadata fetched: August 29, 2026 00:26